These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 28699066)
1. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases. Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066 [TBL] [Abstract][Full Text] [Related]
2. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients. Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654 [TBL] [Abstract][Full Text] [Related]
3. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas. Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J J Neurosurg; 2020 Jan; 132(1):140-149. PubMed ID: 30641849 [TBL] [Abstract][Full Text] [Related]
4. Disease outcomes for skull base and spinal chordomas: a single center experience. Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662 [TBL] [Abstract][Full Text] [Related]
6. Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies. Di Maio S; Temkin N; Ramanathan D; Sekhar LN J Neurosurg; 2011 Dec; 115(6):1094-105. PubMed ID: 21819197 [TBL] [Abstract][Full Text] [Related]
7. Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients. Yasuda M; Bresson D; Chibbaro S; Cornelius JF; Polivka M; Feuvret L; Takayasu M; George B Neurosurg Rev; 2012 Apr; 35(2):171-82; discussion 182-3. PubMed ID: 21863225 [TBL] [Abstract][Full Text] [Related]
8. Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas. Sanusi O; Arnaout O; Rahme RJ; Horbinski C; Chandler JP World Neurosurg; 2018 Jul; 115():e13-e21. PubMed ID: 29545225 [TBL] [Abstract][Full Text] [Related]
9. Endonasal Endoscopic Resection and Radiotherapy in Skull Base Chordomas. Zhang HK; Sun XC; Hu L; Wang JJ; Wang DH J Craniofac Surg; 2016 Oct; 27(7):e709-e713. PubMed ID: 27564072 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic endonasal resection and radiotherapy as treatment for skull base chordomas. Li H; Zhang H; Hu L; Wang H; Wang D Acta Otolaryngol; 2020 Sep; 140(9):789-794. PubMed ID: 32804560 [TBL] [Abstract][Full Text] [Related]
11. Factors for tumor progression in patients with skull base chordoma. Wang L; Tian K; Wang K; Ma J; Ru X; Du J; Jia G; Zhang L; Wu Z; Zhang J Cancer Med; 2016 Sep; 5(9):2368-77. PubMed ID: 27546605 [TBL] [Abstract][Full Text] [Related]
12. Skull base chordomas: clinical outcome in a consecutive series of 45 patients with long-term follow-up and evaluation of clinical and biological prognostic factors. Boari N; Gagliardi F; Cavalli A; Gemma M; Ferrari L; Riva P; Mortini P J Neurosurg; 2016 Aug; 125(2):450-60. PubMed ID: 26745472 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas. Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670 [TBL] [Abstract][Full Text] [Related]
14. Male sex as a risk factor for the clinical course of skull base chordomas. Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075 [TBL] [Abstract][Full Text] [Related]
15. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas. Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429 [TBL] [Abstract][Full Text] [Related]
16. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma. Hoppe M; Gersey ZC; Muthiah N; Abdallah HM; Plute T; Abou-Al-Shaar H; Wang EW; Snyderman CH; Zenonos GA; Gardner PA Neurosurg Focus; 2024 May; 56(5):E16. PubMed ID: 38691858 [TBL] [Abstract][Full Text] [Related]
17. The treatment outcome depending on the extent of resection in skull base and spinal chordomas. Eid AS; Chang UK; Lee SY; Jeon DG Acta Neurochir (Wien); 2011 Mar; 153(3):509-16. PubMed ID: 21207074 [TBL] [Abstract][Full Text] [Related]
18. Clival chordoma: a single-centre outcome analysis. Jägersberg M; El Rahal A; Dammann P; Merkler D; Weber DC; Schaller K Acta Neurochir (Wien); 2017 Oct; 159(10):1815-1823. PubMed ID: 28478512 [TBL] [Abstract][Full Text] [Related]
19. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy. Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365 [TBL] [Abstract][Full Text] [Related]
20. Cranial base chordoma--long term outcome and review of the literature. Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]